These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 1669569

  • 1. Pollinex Parietaria (Bencard Parietaria), a new allergoid for treatment of patients sensitive to Parietaria pollen.
    Resta O, Carnimeo N, Foschino MP, Taylor I, Wheeler AW, Youlten LJ.
    J Investig Allergol Clin Immunol; 1991 Apr; 1(2):129-37. PubMed ID: 1669569
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE, Monasterolo G, Coco G, Operti D.
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Efficacy of sublingual coseasonal immunotherapy with a monomeric allergoid in Cupressaceae pollen allergy--preliminary data.
    Ariano R, Panzani RC, Mistrello G.
    Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):103-8. PubMed ID: 15918297
    [Abstract] [Full Text] [Related]

  • 7. Clinical efficacy and safety of a depigmented and glutaraldehyde polymerized therapeutic vaccine of Parietaria judaica.
    García-Sellés J, Pascual A, Funes E, Pagán JA, López JD, Negro JM, Hernández J.
    Allergol Immunopathol (Madr); 2003 Mar; 31(2):63-9. PubMed ID: 12646120
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Level of specific IgE and IgG in blood serum of patients with hay fever after several cycles of desensitization with pollinex vaccine].
    Szymański W.
    Pol Tyg Lek; 2003 Mar; 46(22-23):412-4. PubMed ID: 1669077
    [Abstract] [Full Text] [Related]

  • 10. Immunotherapy with a mass unit Parietaria judaica extract: a tolerance study with evidence of immunological changes to the major allergen Par j 1.
    García Villalmanzo I, Hernández MD, Campos A, Giner AM, Polo F, Cortés C, Basomba A.
    J Investig Allergol Clin Immunol; 1999 Mar; 9(5):321-9. PubMed ID: 10582201
    [Abstract] [Full Text] [Related]

  • 11. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
    Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.
    Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study.
    Tari MG, Mancino M, Ghezzi E, Frank E, Cromwell O.
    Allergy; 1997 Jan; 52(1):65-74. PubMed ID: 9062631
    [Abstract] [Full Text] [Related]

  • 14. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects.
    Ceuppens JL, Bullens D, Kleinjans H, van der Werf J, PURETHAL Birch Efficacy Study Group.
    Clin Exp Allergy; 2009 Dec; 39(12):1903-9. PubMed ID: 20085600
    [Abstract] [Full Text] [Related]

  • 15. Local intranasal immunotherapy with allergen in powder in atopic patients sensitive to Parietaria officinalis pollen.
    Ariano R, Panzani RC, Chiapella M, Augeri G, Falagiani P.
    J Investig Allergol Clin Immunol; 1995 Dec; 5(3):126-32. PubMed ID: 7582157
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever.
    Ortolani C, Pastorello EA, Incorvaia C, Ispano M, Farioli L, Zara C, Pravettoni V, Zanussi C.
    Allergy; 1994 Jan; 49(1):13-21. PubMed ID: 8198235
    [Abstract] [Full Text] [Related]

  • 17. Monitoring of specific IgG4 antibodies in respiratory allergy due to the pollen of Parietaria judaica. Evidence for a protective role.
    Panzani RC, Ariano R, Augeri G.
    Allergol Immunopathol (Madr); 1996 Jan; 24(6):263-8. PubMed ID: 9010562
    [Abstract] [Full Text] [Related]

  • 18. Genetically engineered hybrid proteins from Parietaria judaica pollen for allergen-specific immunotherapy.
    González-Rioja R, Ibarrola I, Arilla MC, Ferrer A, Mir A, Andreu C, Martínez A, Asturias JA.
    J Allergy Clin Immunol; 2007 Sep; 120(3):602-9. PubMed ID: 17561242
    [Abstract] [Full Text] [Related]

  • 19. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment.
    Subiza J, Feliú A, Subiza JL, Uhlig J, Fernández-Caldas E.
    Clin Exp Allergy; 2008 Jun; 38(6):987-94. PubMed ID: 18445082
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.